QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, March 7, 2007, 27(10):2570-2581; doi:10.1523/JNEUROSCI.3728-06.2007

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Xu, M. Articles by Chavkin, C. Search for Related Content PubMed PubMed Citation Articles by Xu, M. Articles by Chavkin, C.

 Previous Article  |  Next Article 

Development/Plasticity/Repair
Sciatic Nerve Ligation-Induced Proliferation of Spinal Cord Astrocytes Is Mediated by Opioid Activation of p38 Mitogen-Activated Protein Kinase

Mei Xu, Michael R. Bruchas, Danielle L. Ippolito, Louis Gendron, and Charles Chavkin

Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington 98195

Correspondence should be addressed to Dr. Charles Chavkin, Department of Pharmacology, University of Washington School of Medicine, Seattle, WA 98195-7280. Email: cchavkin{at}u.washington.edu

Partial sciatic nerve ligation (pSNL) markedly increased glial fibrillary acidic protein immunoreactivity (GFAP-IR) 1 week after lesion in the L4–L5 spinal dorsal horn of wild-type, but not in dynorphin knock-out, mice lacking opioid receptors (KOR^–/–) or in wild-type mice pretreated with the KOR antagonist nor-binaltorphimine (norBNI). A direct effect of KOR on glial cell proliferation was suggested by the findings that primary cultures of type II GFAP-immunoreactive astrocytes isolated from mouse spinal cord express KOR. Sustained treatment with the agonist U50,488 (trans-3,4-dichloro-N-methyl-N-[2-(1-pyrolytinil)-cyclohexyl]-benzeneacetamide methane sulfonate) significantly increased the proliferation rate of GFAP-immunoreactive astrocytes isolated from wild-type mice, and this effect was blocked by norBNI pretreatment. Proliferation of cultured type II astrocytes may have been stimulated by mitogen-activated protein kinase (MAPK) activation by KOR because (1) U50,488 treatment increased phospho-p38 MAPK-immunoreactivity 247 ± 44% over untreated cells, (2) the increase in phospho-p38 induced by U50,488 was blocked by norBNI and not evident in KOR^–/– cultures, and (3) GFAP-immunoreactive astrocyte proliferation induced by U50,488 was blocked by the p38 MAPK inhibitor SB 203580 [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole]. Similar mechanisms of astrocyte activation may also be responsible in vivo because intrathecal injection of SB 203580 blocked the increased GFAP-IR in lumbar spinal cord induced by pSNL. Although the relationship between -stimulated astrocyte proliferation and neuropathic pain mechanisms was not directly established in these studies, the results support the hypothesis that KOR activation induces spinal astrocyte proliferation, which may contribute to cellular reorganization after sciatic nerve damage.

Key words: KOR; dynorphin; neuropathic pain; phospho-p38; MAPK kinase; G-protein-coupled receptor kinase

---

Received Feb. 10, 2006; revised Jan. 31, 2006; accepted Feb. 1, 2007.

Correspondence should be addressed to Dr. Charles Chavkin, Department of Pharmacology, University of Washington School of Medicine, Seattle, WA 98195-7280. Email: cchavkin{at}u.washington.edu

This article has been cited by other articles:

				B. B. Land, M. R. Bruchas, J. C. Lemos, M. Xu, E. J. Melief, and C. Chavkin The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin {kappa}-Opioid System J. Neurosci., January 9, 2008; 28(2): 407 - 414. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help